Related Experiment Videos
Cancer vaccines and immunotherapy
Said Dermime1, Anne Armstrong, Robert E Hawkins
1CRC Department of Medical Oncology, University of Manchester and Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Manchester, UK.
British Medical Bulletin
|August 15, 2002
Summary
Human tumors possess unique antigens recognized by the immune system. Research into these tumor antigens and immune responses is paving the way for novel cancer vaccines and treatments.
Area of Science:
- Immunology
- Oncology
- Vaccinology
Background:
- Human tumors express unique antigens that can be recognized by the immune system.
- Tumor antigens are classified into categories such as cancer-testis, differentiation, tissue-specific, over-expressed, and viral-associated.
- The molecular basis of carcinogenesis explains the differential expression of these antigens in tumors versus normal cells.
Purpose of the Study:
- To explore the potential of tumor antigens in cancer immunotherapy.
- To understand the immune response to tumor antigens for improved vaccine design.
- To evaluate various cancer vaccine strategies for clinical application.
Main Methods:
- Classification of human tumor antigens.
- Investigation of the molecular basis of carcinogenesis and antigen expression.
- Pre-clinical comparative studies of vaccine strategies.
- Analysis of immune recognition and T-cell activation.
Main Results:
- Identification and classification of diverse tumor antigens.
- Understanding the link between carcinogenesis and antigen expression.
- Evaluation of different vaccine platforms (tumor cells, proteins, peptides, viral vectors, DNA, dendritic cells).
Conclusions:
- Advances in understanding tumor antigens and immune responses are crucial for cancer vaccine development.
- Pre-clinical studies guide the selection of optimal vaccine strategies for clinical trials.
- Cancer vaccines represent a promising new frontier in cancer treatment modalities.